Heartflow, Inc. reported $212M of revenue over the trailing twelve months, +43% on the year before. 9 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $212M (to Q2 2026). Net income: −$118M, trailing twelve months to Q2 2026. Free cash flow: −$59M, trailing twelve months to Q2 2026. Operating margin: −38%, trailing twelve months to Q2 2026.

HTFLHeartflow, Inc.

Healthcare

$49.71+51% 1Y

$49.71

$20.4952 weeks$52.16

HTFL as reported

Heartflow, Inc. reported $212M of revenue over the trailing twelve months, +43% on the year before. 9 reported series are charted on this page, each one as filed.

$212M

Revenue, trailing twelve months · to Q2 2026 · +43% against the twelve months before

Net income: −$118M
Net income · +26% year on year · trailing twelve months to Q2 2026
Free cash flow: −$59M
Free cash flow · −13% year on year · trailing twelve months to Q2 2026
Operating margin: −38%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for HTFL, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$212M	+43%	Q2 2026
Net income	−$118M	+26%	Q2 2026
EPS	−$0.24	−98%	Q2 2026
Gross margin	80%	n/a	Q2 2026
Operating margin	−38%	n/a	Q2 2026
Net margin	−59%	n/a	Q2 2026
ROE	−42%	n/a	Q2 2026
ROA	−33%	n/a	Q2 2026
Free cash flow	−$59M	−13%	Q2 2026

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.